Salim Haffar, PCI Pharma CEO
PCI further expands into New England with fill-finish upgrade in New Hampshire
A Philadelphia-based CDMO will drop $100 million into its aseptic liquid fill-finish and sterile lyophilization technology at its recently-acquired Bedford, NH …
Sign up to read this article for free.
Get free access to a limited number of articles, plus choose newsletters to get straight to your inbox.